Search For "usfda scrutiny"
Indian pharma sector to log 7-9% growth in FY26 despite US headwinds: ICRA
Updated : 7 months, 3 weeks ago IST
India's pharmaceutical industry is set to record healthy revenue growth of 7-9 per cent in FY26, even as challenges in the United States market continue to weigh on performance, noted rating agency ICRA in its latest sector outlook.
Read More